Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 158 results for "orchid chemicals and pharmaceuticals"

Promoter group to infuse Rs 92 crore in Orchid Pharma
Business Standard

Promoter group to infuse Rs 92 crore in Orchid Pharma

The fund infusion through preferential allotment is part of CDR package BS Reporter | Chennai November 26, 2014 Last Updated at 20:30 IST Orchid Healthcare Pvt Ltd, a promoter group firm of Orchid Chemicals and Pharmaceuticals Ltd, would pick up stakes to ... Business Standard, 2 days ago

1 images for "orchid chemicals and pharmaceuticals"

ABC News 4 Charleston, 3 weeks ago
Business Standard India

Relief for Pharma Major Named Defaulter by Bank

CHENNAI: In a relief to beleaguered Orchid Chemicals and Pharmaceuticals Ltd, Madras High Court has set aside ING Vysya Bank declaring the pharma major as a willful defaulter and publish photographs of company's CMD K Raghavendra Rao and that of the ...
 New Indian Express1 week ago Orchid Pharma eyes full-capacity utilisation  Business Standard India1 week ago Orchid Chemicals & Pharmaceuticals reports standalone net profit of Rs 271.94 crore in the September 2014 quarter  Business Standard2 weeks ago Orchid Chemicals may head above Rs 80: Pritesh Mehta  Money Control2 weeks ago
[x]  

Gains from business transfer put Orchid Chem in the black in Q2

Orchid Chemicals and Pharmaceuticals has reported a net profit for the quarter ended September 30 due to extraordinary gain from transfer of the Penicillin and Penem API business. After adjusting for the extraordinary gain of ₹319 crore from ...
 Hindu Business Line2 weeks ago Orchid Chemicals & Pharmaceuticals : Gains from business transfer put Orchid Chem in the black in Q2  4 Traders1 week ago
Financial Express

Natco Pharma Limited, Hit With A Strong Dose Of FDA Medicine

4:35 am Natco Pharma and Orchid Chemicals and Pharmaceuticals have received an adverse observation report, commonly known as Form 483, after inspections conducted in their manufacturing units earlier this year by the US Food and Drug ...
 BioSpace2 months ago Orchid Chemicals & Pharmaceuticals : NATCO, ORCHID GETS A STRONG DOSE OF US FDA MEDICINE  4 Traders2 months ago Natco Pharma, Orchid Chemicals get a strong dose of US FDA medicine  Financial Express2 months ago
Business Standard

Madras HC orders against ING Vysya's move to announce Orchid Pharma as wilful defaulter

The Court says that the decision is taken keeping the larger public interest in mind, as 25 other banks are involved BS Reporter | Chennai November 17, 2014 Last Updated at 20:20 IST The Madras High Court has issued an order in favour of a petition filed by ...
 Business Standard1 week ago

Poonawalla awaits right price for stake in Orchid Chemicals

Cyrus Poonawalla, the billionaire horse breeder and chairman of Serum Institute, one of the world's largest vaccine makers, has said he would entertain an offer for his 14.5% stake in Orchid Chemicals at the right price. There's buzz in the market ...
 Times of India1 month ago CYRUS POONAWALLA : Poonawalla awaits right price for stake in Orchid Chemicals  4 Traders4 weeks ago

Pharmaceutical Newsletter - November 24 to 28, 2014

Top News US court not granted Ranbaxy appeal to block ANDA nod Ranbaxy Laboratories Ltd said that the Court has not granted Temporary Restraining Order to block FDA approval for other ANDAs for generic version of Nexium and Valganciclovir.
 India Infoline10 hours ago

Net sales of 50 major pharma cos up by 14%, EBDITA by 15.5% in first half of 2014-15

Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian pharmaceutical companies registered satisfactory growth in net sales and earnings before depreciation, ...
 PharmaBiz4 days ago

More FDA issues arise for Hospira in India

Plant it bought in Orchid deal cited with Form 483 and observations Share Tools Hospira, already dealing with FDA problems at two plants in India, has bought itself some more issues with the FDA. About three months before Hospira closed on its ...
 FiercePharmaManufacturing2 months ago New FDA concerns arise for Hospira plant in Australia  FiercePharmaManufacturing1 month ago

Top corporate news of the day - November 27, 2014

Oil and Natural Gas Corp has finalized a price between $10.10 and $11.20 per unit for gas produced from its marginal fields, oil minister Dharmendra Pradhan has said. (BS) Rating agency Moody's has downgraded Indian Overseas Bank's financial ...
 India Infoline1 day ago Top Corporate News of the day-18 November, 2014  India Infoline1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less